Video Experimental Relacionado

Updated: Jan 13, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

GRK2 y GRK5: Las 2 quinasas críticas en la fisiopatología cardíaca

Rajika Roy¹, Walter J Koch¹

¹Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke Cardiovascular Research Center, Duke University School of Medicine, Durham, North Carolina.

Molecular pharmacology

|January 6, 2026

Resumen

Las quinasas 2 y 5 de los receptores acoplados a proteínas G (GRK) son actores clave en la insuficiencia cardíaca. Dirigirse a estas quinasas en células cardíacas específicas ofrece una nueva y prometedora estrategia terapéutica para el tratamiento de la insuficiencia cardíaca.

Área de la Ciencia:

Biología Cardiovascular
Farmacología Molecular
Bioquímica

Sus antecedentes:

Las quinasas de receptores acoplados a proteínas G (GRK) regulan la señalización de receptores acoplados a proteínas G.
La GRK2 y la GRK5 se expresan en altos niveles en el corazón y se regulan al alza en la insuficiencia cardíaca (IC).
Estas GRK están presentes en todos los tipos de células cardíacas, incluidos los cardiomiocitos, fibroblastos, células endoteliales y células del músculo liso vascular.

Objetivo del estudio:

Revisar los roles de GRK2 y GRK5 en el desarrollo y progresión de la insuficiencia cardíaca.
Examinar las funciones específicas de las células de GRK2 y GRK5 en la fisiopatología cardíaca.
Discutir el potencial terapéutico de los inhibidores de GRK2 y GRK5 para la insuficiencia cardíaca.

Principales métodos:

Revisión del trabajo de laboratorio seminal y la literatura publicada sobre GRK2 y GRK5 en insuficiencia cardíaca.
Análisis de la expresión y función de GRK en diversos tipos de células cardíacas.
Evaluación de datos preclínicos y clínicos de inhibidores de GRK.

Principales resultados:

La GRK2 y la GRK5 se regulan significativamente al alza en la IC humana y de ratón.
Ambas GRK contribuyen a la fisiopatología de la IC en todos los tipos de células cardíacas.
Se han desarrollado y probado potentes inhibidores de GRK2 y GRK5 en modelos de IC, y un inhibidor de GRK2 (paroxetina) ha entrado en ensayos clínicos.

Conclusiones:

La GRK2 y la GRK5 son centrales en el inicio y la progresión de la insuficiencia cardíaca.
La inhibición de GRK2 y GRK5, considerando sus roles específicos en las células, presenta una nueva vía terapéutica para la IC.
Una mayor investigación sobre inhibidores selectivos de GRK podría conducir a una nueva clase de fármacos para la IC.

Palabras clave:

GRK2 GRK5 Insuficiencia cardíaca Inhibidores

Más Videos Relacionados

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

Videos de Conceptos Relacionados

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Pathophysiology of Cardiac Performance

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

G-Protein Gated Ion Channels

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...